sulofenur has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, SH; Kang, JS; Kim, HM; Kim, NS; Lee, KC; Sharma, VK; Subramanian, S; Thanigaimalai, P | 1 |
Einhorn, LH; Fossella, F; Lippman, SM; Munshi, NC; Seitz, DE | 1 |
Alberts, DS; Fossella, FV; Hardy, J; Haynes, TR; Lippman, SM; O'Brien, M; Seitz, DE; Taylor, CW; Wiltshaw, E; Wolen, RL | 1 |
2 trial(s) available for sulofenur and Lung Neoplasms
Article | Year |
---|---|
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drugs, Investigational; Female; Humans; Lung Neoplasms; Male; Middle Aged; Sulfonylurea Compounds | 1993 |
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Interactions; Female; Humans; Hypoprothrombinemias; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds; Warfarin | 1991 |
1 other study(ies) available for sulofenur and Lung Neoplasms
Article | Year |
---|---|
Structure--activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity.
Topics: Animals; Antineoplastic Agents; Arylsulfonates; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Imidazolidines; Lung Neoplasms; Mice; Mice, Nude; Molecular Conformation; Neoplasm Transplantation; Ovarian Neoplasms; Structure-Activity Relationship | 2011 |